-
1
-
-
84878354080
-
Surgical resection for non-small cell lung cancer: Clinical features and outcomes for a consecutive series at an Irish tertiary referral centre
-
B.S. Al-Alao, D.S. O'Callaghan, K. Gately, S. Nicholson, L.E. Coate, F. O'Connell, E. McGovern, K.J. O'Byrne, and V.K. Young Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre Ir. J. Med. Sci. 182 2013 217 225
-
(2013)
Ir. J. Med. Sci.
, vol.182
, pp. 217-225
-
-
Al-Alao, B.S.1
O'Callaghan, D.S.2
Gately, K.3
Nicholson, S.4
Coate, L.E.5
O'Connell, F.6
McGovern, E.7
O'Byrne, K.J.8
Young, V.K.9
-
2
-
-
84924577472
-
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma
-
J.C. Han, X.D. Li, J. Du, F. Xu, Y.J. Wei, H.B. Li, and Y.J. Zhang Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma World J. Surg. Oncol. 13 2015 5
-
(2015)
World J. Surg. Oncol.
, vol.13
, pp. 5
-
-
Han, J.C.1
Li, X.D.2
Du, J.3
Xu, F.4
Wei, Y.J.5
Li, H.B.6
Zhang, Y.J.7
-
3
-
-
79952232216
-
Global cancer statistics
-
A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
-
(2011)
CA Cancer J. Clin.
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
4
-
-
56849133040
-
DNA methylation-based biomarkers for early detection of non-small cell lung cancer: An update
-
P.P. Anglim, T.A. Alonzo, and I.A. Laird-Offringa DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update Mol. Cancer 7 2008 81
-
(2008)
Mol. Cancer
, vol.7
, pp. 81
-
-
Anglim, P.P.1
Alonzo, T.A.2
Laird-Offringa, I.A.3
-
5
-
-
77951880109
-
A phase i clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions
-
X. Wang, J. Zhou, Y. Wang, Z. Zhu, Y. Lu, Y. Wei, and L. Chen A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions Eur. J. Cancer 46 2010 1474 1480
-
(2010)
Eur. J. Cancer
, vol.46
, pp. 1474-1480
-
-
Wang, X.1
Zhou, J.2
Wang, Y.3
Zhu, Z.4
Lu, Y.5
Wei, Y.6
Chen, L.7
-
6
-
-
60349084045
-
Epidemiology of lung cancer prognosis: Quantity and quality of life
-
P. Yang Epidemiology of lung cancer prognosis: quantity and quality of life Methods Mol. Biol. 471 2009 469 486
-
(2009)
Methods Mol. Biol.
, vol.471
, pp. 469-486
-
-
Yang, P.1
-
7
-
-
33746069404
-
In control of biology: Of mice, men and Foxes
-
P.J. Wijchers, J.P. Burbach, and M.P. Smidt In control of biology: of mice, men and Foxes Biochem. J. 397 2006 233 246
-
(2006)
Biochem. J.
, vol.397
, pp. 233-246
-
-
Wijchers, P.J.1
Burbach, J.P.2
Smidt, M.P.3
-
8
-
-
35548930209
-
The emerging roles of forkhead box (Fox) proteins in cancer
-
S.S. Myatt, and E.W. Lam The emerging roles of forkhead box (Fox) proteins in cancer Nat. Rev. Cancer 7 2007 847 859
-
(2007)
Nat. Rev. Cancer
, vol.7
, pp. 847-859
-
-
Myatt, S.S.1
Lam, E.W.2
-
9
-
-
84898014753
-
FoxD3 deficiency promotes breast cancer progression by induction of epithelial-mesenchymal transition
-
T.L. Chu, H.M. Zhao, Y. Li, A.X. Chen, X. Sun, and J. Ge FoxD3 deficiency promotes breast cancer progression by induction of epithelial-mesenchymal transition Biochem. Biophys. Res. Commun. 446 2014 580 584
-
(2014)
Biochem. Biophys. Res. Commun.
, vol.446
, pp. 580-584
-
-
Chu, T.L.1
Zhao, H.M.2
Li, Y.3
Chen, A.X.4
Sun, X.5
Ge, J.6
-
10
-
-
10144256494
-
Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells
-
J. Sutton, R. Costa, M. Klug, L. Field, D. Xu, D.A. Largaespada, C.F. Fletcher, N.A. Jenkins, N.G. Copeland, M. Klemsz, and R. Hromas Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells J. Biol. Chem. 271 1996 23126 23133
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 23126-23133
-
-
Sutton, J.1
Costa, R.2
Klug, M.3
Field, L.4
Xu, D.5
Largaespada, D.A.6
Fletcher, C.F.7
Jenkins, N.A.8
Copeland, N.G.9
Klemsz, M.10
Hromas, R.11
-
11
-
-
56249127149
-
The making of a melanocyte: The specification of melanoblasts from the neural crest
-
A.J. Thomas, and C.A. Erickson The making of a melanocyte: the specification of melanoblasts from the neural crest Pigment. Cell Melanoma Res. 21 2008 598 610
-
(2008)
Pigment. Cell Melanoma Res.
, vol.21
, pp. 598-610
-
-
Thomas, A.J.1
Erickson, C.A.2
-
12
-
-
84871296892
-
Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis
-
e9
-
A.S. Cheng, M.S. Li, W. Kang, V.Y. Cheng, J.L. Chou, S.S. Lau, M.Y. Go, C.C. Lee, T.K. Ling, E.K. Ng, J. Yu, T.H. Huang, K.F. To, M.W. Chan, J.J. Sung, and F.K. Chan Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis Gastroenterology 144 2013 122 133 e9
-
(2013)
Gastroenterology
, vol.144
, pp. 122-133
-
-
Cheng, A.S.1
Li, M.S.2
Kang, W.3
Cheng, V.Y.4
Chou, J.L.5
Lau, S.S.6
Go, M.Y.7
Lee, C.C.8
Ling, T.K.9
Ng, E.K.10
Yu, J.11
Huang, T.H.12
To, K.F.13
Chan, M.W.14
Sung, J.J.15
Chan, F.K.16
-
13
-
-
77950847051
-
FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells
-
E.V. Abel, and A.E. Aplin FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells Cancer Res. 70 2010 2891 2900
-
(2010)
Cancer Res.
, vol.70
, pp. 2891-2900
-
-
Abel, E.V.1
Aplin, A.E.2
-
14
-
-
84907277121
-
FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma
-
M.B. Weiss, E.V. Abel, N. Dadpey, and A.E. Aplin FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma Mol. Cancer Res. 12 2014 1314 1323
-
(2014)
Mol. Cancer Res.
, vol.12
, pp. 1314-1323
-
-
Weiss, M.B.1
Abel, E.V.2
Dadpey, N.3
Aplin, A.E.4
-
15
-
-
79956017928
-
FOXD3 regulates migration properties and Rnd3 expression in melanoma cells
-
P. Katiyar, and A.E. Aplin FOXD3 regulates migration properties and Rnd3 expression in melanoma cells Mol. Cancer Res. 9 2011 545 552
-
(2011)
Mol. Cancer Res.
, vol.9
, pp. 545-552
-
-
Katiyar, P.1
Aplin, A.E.2
-
16
-
-
84890167506
-
FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma
-
D. Li, H. Mei, M. Qi, D. Yang, X. Zhao, X. Xiang, J. Pu, K. Huang, L. Zheng, and Q. Tong FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma Oncotarget 4 2013 2021 2044
-
(2013)
Oncotarget
, vol.4
, pp. 2021-2044
-
-
Li, D.1
Mei, H.2
Qi, M.3
Yang, D.4
Zhao, X.5
Xiang, X.6
Pu, J.7
Huang, K.8
Zheng, L.9
Tong, Q.10
-
17
-
-
84891833726
-
Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/beta-catenin signaling
-
W. Lu, Z. Fu, H. Wang, J. Feng, J. Wei, and J. Guo Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/beta-catenin signaling Cancer Lett. 343 2014 190 199
-
(2014)
Cancer Lett.
, vol.343
, pp. 190-199
-
-
Lu, W.1
Fu, Z.2
Wang, H.3
Feng, J.4
Wei, J.5
Guo, J.6
-
18
-
-
84878529330
-
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia
-
Y. Chen, R. Jacamo, M. Konopleva, R. Garzon, C. Croce, and M. Andreeff CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia J. Clin. Invest 123 2013 2395 2407
-
(2013)
J. Clin. Invest
, vol.123
, pp. 2395-2407
-
-
Chen, Y.1
Jacamo, R.2
Konopleva, M.3
Garzon, R.4
Croce, C.5
Andreeff, M.6
-
19
-
-
84910134804
-
MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1
-
Z.G. Zhang, W.X. Chen, Y.H. Wu, H.F. Liang, and B.X. Zhang MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1 Biochem. Biophys. Res. Commun. 454 2014 109 114
-
(2014)
Biochem. Biophys. Res. Commun.
, vol.454
, pp. 109-114
-
-
Zhang, Z.G.1
Chen, W.X.2
Wu, Y.H.3
Liang, H.F.4
Zhang, B.X.5
-
20
-
-
84898903594
-
Angiogenesis in cancer - General pathways and their therapeutic implications
-
I. Dimova, G. Popivanov, and V. Djonov, Angiogenesis in cancer - general pathways and their therapeutic implications, J. Buon 19 15-21.
-
J. Buon
, vol.19
, pp. 15-21
-
-
Dimova, I.1
Popivanov, G.2
Djonov, V.3
-
21
-
-
84855991351
-
ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer
-
W. Zhou, L. Wang, S.M. Gou, T.L. Wang, M. Zhang, T. Liu, and C.Y. Wang ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer Cancer Lett. 316 2012 178 186
-
(2012)
Cancer Lett.
, vol.316
, pp. 178-186
-
-
Zhou, W.1
Wang, L.2
Gou, S.M.3
Wang, T.L.4
Zhang, M.5
Liu, T.6
Wang, C.Y.7
-
22
-
-
84870376109
-
Cancer genetics and genomics of human FOX family genes
-
M. Katoh, M. Igarashi, H. Fukuda, and H. Nakagama Cancer genetics and genomics of human FOX family genes Cancer Lett. 328 2013 198 206
-
(2013)
Cancer Lett.
, vol.328
, pp. 198-206
-
-
Katoh, M.1
Igarashi, M.2
Fukuda, H.3
Nakagama, H.4
-
23
-
-
0037108047
-
Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo
-
L.A. Hanna, R.K. Foreman, I.A. Tarasenko, D.S. Kessler, and P.A. Labosky Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo Genes Dev. 16 2002 2650 2661
-
(2002)
Genes Dev.
, vol.16
, pp. 2650-2661
-
-
Hanna, L.A.1
Foreman, R.K.2
Tarasenko, I.A.3
Kessler, D.S.4
Labosky, P.A.5
-
24
-
-
24144483067
-
Foxd3 is required in the trophoblast progenitor cell lineage of the mouse embryo
-
D.M. Tompers, R.K. Foreman, Q. Wang, M. Kumanova, and P.A. Labosky Foxd3 is required in the trophoblast progenitor cell lineage of the mouse embryo Dev. Biol. 285 2005 126 137
-
(2005)
Dev. Biol.
, vol.285
, pp. 126-137
-
-
Tompers, D.M.1
Foreman, R.K.2
Wang, Q.3
Kumanova, M.4
Labosky, P.A.5
-
25
-
-
77950847051
-
FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells
-
E.V. Abel, and A.E. Aplin, FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells, Cancer Res. 70 2891-2900.
-
Cancer Res.
, vol.70
, pp. 2891-2900
-
-
Abel, E.V.1
Aplin, A.E.2
-
26
-
-
84898903594
-
Angiogenesis in cancer - General pathways and their therapeutic implications
-
I. Dimova, G. Popivanov, and V. Djonov Angiogenesis in cancer - general pathways and their therapeutic implications J. BUON 19 2014 15 21
-
(2014)
J. BUON
, vol.19
, pp. 15-21
-
-
Dimova, I.1
Popivanov, G.2
Djonov, V.3
|